Daniele Alberti

4.3k total citations · 1 hit paper
25 papers, 2.9k citations indexed

About

Daniele Alberti is a scholar working on Genetics, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Daniele Alberti has authored 25 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 14 papers in Hematology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Daniele Alberti's work include Hemoglobinopathies and Related Disorders (11 papers), Iron Metabolism and Disorders (9 papers) and Blood Pressure and Hypertension Studies (8 papers). Daniele Alberti is often cited by papers focused on Hemoglobinopathies and Related Disorders (11 papers), Iron Metabolism and Disorders (9 papers) and Blood Pressure and Hypertension Studies (8 papers). Daniele Alberti collaborates with scholars based in Italy, Switzerland and Canada. Daniele Alberti's co-authors include Giuseppe Maschio, P Zucchelli, Johannes F.E. Mann, Eberhard Ritz, G. Janin, M Motolese, Francesco Locatelli, Claudio Ponticelli, Romain Séchaud and Renzo Galanello and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Daniele Alberti

25 papers receiving 2.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency

1996 1.3k citations Giuseppe Maschio, Daniele Alberti et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniele Alberti Italy	14	1.2k	1.2k	896	754	416	25	2.9k
W. Kline Bolton United States	32	1.2k 1.0×	687 0.6×	461 0.5×	2.0k 2.6×	567 1.4×	81	4.6k
Lucia Del Vecchio Italy	34	1.2k 1.0×	401 0.3×	426 0.5×	2.4k 3.2×	391 0.9×	175	4.0k
Simon D. Roger Australia	30	1.4k 1.2×	635 0.5×	626 0.7×	1.1k 1.5×	159 0.4×	88	3.7k
G Mecca Italy	31	873 0.7×	325 0.3×	487 0.5×	1.4k 1.8×	276 0.7×	59	3.4k
Iain C. Macdougall United Kingdom	35	2.7k 2.3×	1.2k 1.0×	417 0.5×	1.1k 1.4×	73 0.2×	83	3.8k
Claudio Mori Italy	26	2.3k 2.0×	930 0.8×	1.7k 1.9×	266 0.4×	144 0.3×	72	4.2k
Jay B. Wish United States	23	1.2k 1.0×	587 0.5×	205 0.2×	1.5k 2.0×	71 0.2×	92	3.0k
Dimitrios Tsakiris United Kingdom	12	1.4k 1.2×	454 0.4×	289 0.3×	1.2k 1.5×	106 0.3×	22	2.3k
Bradley J. Maroni United States	26	948 0.8×	177 0.2×	181 0.2×	2.0k 2.6×	149 0.4×	41	3.1k
Mauro Berrettini Italy	23	1.2k 1.0×	409 0.3×	1.1k 1.3×	135 0.2×	63 0.2×	53	2.9k

Countries citing papers authored by Daniele Alberti

Since Specialization

Citations

This map shows the geographic impact of Daniele Alberti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniele Alberti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniele Alberti more than expected).

Fields of papers citing papers by Daniele Alberti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniele Alberti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniele Alberti. The network helps show where Daniele Alberti may publish in the future.

Co-authorship network of co-authors of Daniele Alberti

This figure shows the co-authorship network connecting the top 25 collaborators of Daniele Alberti. A scholar is included among the top collaborators of Daniele Alberti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniele Alberti. Daniele Alberti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Walter, Patrick B., John B. Porter, Patricia Evans, et al.. (2012). Increased leucocyte apoptosis in transfused β‐thalassaemia patients. British Journal of Haematology. 160(3). 399–403. 7 indexed citations

Galanello, Renzo, Antonio Piga, Maria Domenica Cappellini, et al.. (2008). Effect of Food, Type of Food, and Time of Food Intake on Deferasirox Bioavailability: Recommendations for an Optimal Deferasirox Administration Regimen. The Journal of Clinical Pharmacology. 48(4). 428–435. 34 indexed citations

Murru, Roberta, et al.. (2007). Correction of anemia in a transfusion‐dependent patient with primary myelofibrosis receiving iron chelation therapy with deferasirox (Exjade^®, ICL670). European Journal Of Haematology. 78(6). 540–542. 51 indexed citations

Walter, Patrick B., John B. Porter, Patricia Evans, et al.. (2007). Leukocyte Apoptosis and Mitochondrial Dysfunction in β-Thalassemia Patients Treated with Deferasirox or Deferoxamine.. Blood. 110(11). 2773–2773. 1 indexed citations

Cilloni, Daniela, Francesca Messa, Enrico Gottardi, et al.. (2004). Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubation. Cancer. 101(5). 979–988. 26 indexed citations

Piga, Antonio, Renzo Galanello, Filomena Longo, et al.. (2004). Once-Daily Treatment with the Oral Iron Chelator ICL670 (Exjade®): Results of a Phase II Study in Pediatric Patients with β-Thalassemia Major.. Blood. 104(11). 3614–3614. 12 indexed citations

Rosti, Gianantonio, Giovanni Martinelli, Simona Bassi, et al.. (2003). Molecular response to imatinib in late chronic-phase chronic myeloid leukemia. Blood. 103(6). 2284–2290. 56 indexed citations

Nisbet‐Brown, Eric, Nancy F. Olivieri, Patricia J. Giardina, et al.. (2003). Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial. The Lancet. 361(9369). 1597–1602. 260 indexed citations

Galanello, Renzo, Antonio Piga, Daniele Alberti, et al.. (2003). Safety, Tolerability, and Pharmacokinetics of ICL670, a New Orally Active Iron‐Chelating Agent in Patients with Transfusion‐Dependent Iron Overload Due to β‐Thalassemia. The Journal of Clinical Pharmacology. 43(6). 565–572. 117 indexed citations

10.

Galanello, Renzo, Antonio Piga, Daniele Alberti, et al.. (2003). Safety, tolerability, and pharmacokinetics of ICL670, a new orally active iron-chelating agent in patients with transfusion-dependent iron overload due to beta-thalassemia.. PubMed. 43(6). 565–72. 150 indexed citations

11.

Gambacorti‐Passerini, Carlo, Massimo Zucchetti, Domenico Russo, et al.. (2003). Alpha1 acid glycoprotein binds to imatinib (STI571) and substantially alters its pharmacokinetics in chronic myeloid leukemia patients.. PubMed. 9(2). 625–32. 182 indexed citations

12.

Bajetta, Emilio, Giuseppe Procopio, Leonardo Ferrari, et al.. (2002). A randomized, multicenter prospective trial assessing long‐acting release octreotide pamoate plus tamoxifen as a first line therapy for advanced breast carcinoma. Cancer. 94(2). 299–304. 30 indexed citations

13.

Maschio, Giuseppe, Daniele Alberti, G. Janin, et al.. (1996). Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency. New England Journal of Medicine. 334(15). 939–945. 1335 indexed citations breakdown →

14.

Alberti, Daniele, G. Graziani, G. Buccianti, et al.. (1993). Hypertension and Chronic Renal Insufficiency: The Experience of the Northern Italian Cooperative Study Group. American Journal of Kidney Diseases. 21(5). 124–130. 7 indexed citations

15.

Bedogna, Valeria, et al.. (1990). Effects of ACE inhibition in normotensive patients with chronic glomerular disease and normal renal function. Kidney International. 38(1). 101–107. 55 indexed citations

16.

Valvo, E., et al.. (1990). Systemic and renal effects of a new angiotensin converting enzyme inhibitor, benazepril, in essential hypertension. Journal of Hypertension. 8(11). 991–995. 13 indexed citations

17.

Pollavini, G, et al.. (1988). Effects of a low-sodium high-potassium salt in hypertensive patients treated with metoprolol. Journal of Hypertension. 6(10). 787???790–787???790. 16 indexed citations

18.

Antivalle, M., et al.. (1987). Slow-Release Metoprolol and Nifedipine in Essential Hypertension. Journal of Cardiovascular Pharmacology. 10. S99–101. 1 indexed citations

19.

Antivalle, M., et al.. (1987). Slow-Release Metoprolol and Nifedipine in Essential Hypertension. Journal of Cardiovascular Pharmacology. 10. S99–101. 4 indexed citations

20.

Radice, M, Daniele Alberti, Fausto Avanzini, et al.. (1985). Long-term Efficacy of Screening for Hypertension in a Community. Journal of Hypertension. 3(3). 255–259. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact